Your browser doesn't support javascript.
loading
Obstructive sleep apnea and weight loss treatment outcome among adults with metabolic syndrome.
Whited, Matthew C; Olendzki, Effie; Ma, Yunsheng; Waring, Molly E; Schneider, Kristin L; Appelhans, Bradley M; Busch, Andrew M; Chesebro, James; Pagoto, Sherry L.
Afiliación
  • Whited MC; Department of Psychology.
  • Olendzki E; Department of Medicine, Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School.
  • Ma Y; Department of Medicine, Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School.
  • Waring ME; Department of Quantitative Health Sciences.
  • Schneider KL; Department of Psychology, Rosalind Franklin University of Medicine and Science.
  • Appelhans BM; Department of Preventive Medicine, Rush University Medical Center.
  • Busch AM; Miriam Hospital, Centers for Behavioral and Preventive Medicine.
  • Chesebro J; Department of Medicine/Cardiovascular Disease, University of Massachusetts Medical School.
  • Pagoto SL; Department of Medicine, Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School.
Health Psychol ; 35(12): 1316-1319, 2016 Dec.
Article en En | MEDLINE | ID: mdl-27294597
OBJECTIVE: The purpose of this study was to examine whether adults with obesity and metabolic syndrome who screen as high risk for obstructive sleep apnea (OSA) lose less weight as part of a weight loss intervention than those who screen as low risk. METHOD: We conducted a secondary analysis of a randomized trial comparing 2 weight loss interventions consisting of dietary counseling for adults with obesity and metabolic syndrome. Participants were screened for sleep apnea using a validated screening questionnaire. Percent weight loss was calculated from weight measured at baseline and intervention end (12 months). Weight loss of 5% or greater was considered clinically significant. Multivariate linear and logistic regression models estimated the association between OSA screening status (high vs. low risk) and percent weight loss and clinically significant weight loss, adjusting for relevant covariates including body mass index and sleep duration. RESULTS: Nearly half of participants (45.8%) screened as high risk for OSA. Participants who screened as high risk for OSA lost less weight (1.2% ± 4.2% vs. 4.2% ± 5.3%) and were less likely to lose 5% or greater (24.4% vs. 75.6%) than participants without OSA. CONCLUSION: Among adults with obesity and metabolic syndrome, those at high risk for OSA lost less weight in response to a dietary counseling intervention than adults with low risk of OSA. Routine OSA screening should be considered as part of weight loss treatment programs. Additional research is needed to determine how to tailor weight loss treatment for those with high risk for OSA. (PsycINFO Database Record
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pérdida de Peso / Apnea Obstructiva del Sueño / Síndrome Metabólico Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Health Psychol Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pérdida de Peso / Apnea Obstructiva del Sueño / Síndrome Metabólico Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Health Psychol Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos